A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

The booster shot – called mRNA-1273.211 ... be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking ...

Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.

Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...

The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter.

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

Dr. Adam Ratner joins Morning Joe to discuss his new book 'Booster Shots: The Urgent Lessons of Measles and the Uncertain ...

With the foundational research toward mRNA vaccines laid, when SARS-CoV-2—the coronavirus that causes COVID-19—was identified in China in December 2019, the VPL and Moderna were ready to pivot ...